National Institutes of Health awards TriAltus Bioscience $256,000 NIH grant

A local biotech company has secured a six-figure grant. TriAltus Bioscience has been awarded a $256,576 Phase I Small Business Technology Transfer (STTR) grant from the National Institutes of Health for its project called “Universal affinity membrane chromatography for rapid, one-step purification of proteins" that aims to make use of TriAltus’ pa tented protein purification technology. The highly competitive STTR program funds joint research proposals from small businesses that partner with…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news